nodes	percent_of_prediction	percent_of_DWPC	metapath
Clomipramine—GSTP1—Cisplatin—germ cell cancer	0.241	0.346	CbGbCtD
Clomipramine—GSTP1—Etoposide—germ cell cancer	0.236	0.34	CbGbCtD
Clomipramine—CYP2C19—Ifosfamide—germ cell cancer	0.0401	0.0577	CbGbCtD
Clomipramine—ABCB1—Dactinomycin—germ cell cancer	0.0274	0.0394	CbGbCtD
Clomipramine—ALB—Methotrexate—germ cell cancer	0.0195	0.0281	CbGbCtD
Clomipramine—CYP3A4—Ifosfamide—germ cell cancer	0.0194	0.0279	CbGbCtD
Clomipramine—CYP1A2—Etoposide—germ cell cancer	0.0177	0.0254	CbGbCtD
Clomipramine—ABCB1—Vinblastine—germ cell cancer	0.0172	0.0247	CbGbCtD
Clomipramine—CYP2D6—Vinblastine—germ cell cancer	0.0162	0.0233	CbGbCtD
Clomipramine—ABCB1—Cisplatin—germ cell cancer	0.0157	0.0226	CbGbCtD
Clomipramine—ABCB1—Etoposide—germ cell cancer	0.0155	0.0222	CbGbCtD
Clomipramine—HTR2B—cardial valve—germ cell cancer	0.0108	0.0891	CbGeAlD
Clomipramine—CYP3A4—Vinblastine—germ cell cancer	0.0103	0.0148	CbGbCtD
Clomipramine—ABCB1—Methotrexate—germ cell cancer	0.0102	0.0147	CbGbCtD
Clomipramine—CYP3A4—Etoposide—germ cell cancer	0.00927	0.0133	CbGbCtD
Clomipramine—HTR2C—choroid plexus—germ cell cancer	0.00926	0.0765	CbGeAlD
Clomipramine—HTR2A—phrenic nerve—germ cell cancer	0.00643	0.0531	CbGeAlD
Clomipramine—HTR2A—choroid plexus—germ cell cancer	0.00465	0.0384	CbGeAlD
Clomipramine—HTR2A—myenteric nerve plexus—germ cell cancer	0.0033	0.0272	CbGeAlD
Clomipramine—HTR6—ganglion—germ cell cancer	0.00292	0.0241	CbGeAlD
Clomipramine—GSTP1—urine—germ cell cancer	0.00282	0.0233	CbGeAlD
Clomipramine—HTR2C—telencephalic ventricle—germ cell cancer	0.00271	0.0224	CbGeAlD
Clomipramine—HTR2A—trigeminal nerve—germ cell cancer	0.00235	0.0194	CbGeAlD
Clomipramine—HTR2A—vagus nerve—germ cell cancer	0.0022	0.0181	CbGeAlD
Clomipramine—CYP2C19—urine—germ cell cancer	0.00195	0.0161	CbGeAlD
Clomipramine—HTR2C—ganglion—germ cell cancer	0.00169	0.0139	CbGeAlD
Clomipramine—HTR2A—cranial nerve—germ cell cancer	0.00167	0.0138	CbGeAlD
Clomipramine—HTR2A—pons—germ cell cancer	0.00165	0.0137	CbGeAlD
Clomipramine—SLC6A4—ganglion—germ cell cancer	0.0016	0.0132	CbGeAlD
Clomipramine—CYP1A2—urine—germ cell cancer	0.00159	0.0131	CbGeAlD
Clomipramine—SLC6A2—ganglion—germ cell cancer	0.00141	0.0116	CbGeAlD
Clomipramine—HTR2A—telencephalic ventricle—germ cell cancer	0.00136	0.0112	CbGeAlD
Clomipramine—HTR2A—urine—germ cell cancer	0.00124	0.0103	CbGeAlD
Clomipramine—HTR2A—appendage—germ cell cancer	0.00121	0.00999	CbGeAlD
Clomipramine—HTR2A—pineal body—germ cell cancer	0.00118	0.00975	CbGeAlD
Clomipramine—CYP3A4—urine—germ cell cancer	0.00115	0.0095	CbGeAlD
Clomipramine—CYP2D6—urine—germ cell cancer	0.00113	0.00935	CbGeAlD
Clomipramine—HTR6—telencephalon—germ cell cancer	0.00113	0.00931	CbGeAlD
Clomipramine—GSTP1—neck—germ cell cancer	0.00109	0.00904	CbGeAlD
Clomipramine—HRH2—skin of body—germ cell cancer	0.000984	0.00812	CbGeAlD
Clomipramine—GSTP1—trigeminal ganglion—germ cell cancer	0.000945	0.0078	CbGeAlD
Clomipramine—GSTP1—embryo—germ cell cancer	0.000913	0.00754	CbGeAlD
Clomipramine—HTR2A—ganglion—germ cell cancer	0.000847	0.007	CbGeAlD
Clomipramine—GSTP1—eye—germ cell cancer	0.000814	0.00672	CbGeAlD
Clomipramine—GSTP1—retina—germ cell cancer	0.000807	0.00666	CbGeAlD
Clomipramine—HRH2—adrenal gland—germ cell cancer	0.00075	0.00619	CbGeAlD
Clomipramine—GSTP1—telencephalon—germ cell cancer	0.000742	0.00613	CbGeAlD
Clomipramine—HTR2C—brainstem—germ cell cancer	0.000734	0.00606	CbGeAlD
Clomipramine—HTR2A—endothelium—germ cell cancer	0.000731	0.00603	CbGeAlD
Clomipramine—GSTP1—skin of body—germ cell cancer	0.000708	0.00585	CbGeAlD
Clomipramine—GSTP1—decidua—germ cell cancer	0.000704	0.00581	CbGeAlD
Clomipramine—HTR6—head—germ cell cancer	0.000702	0.0058	CbGeAlD
Clomipramine—SLC6A4—brainstem—germ cell cancer	0.000696	0.00575	CbGeAlD
Clomipramine—HTR2A—blood vessel—germ cell cancer	0.000674	0.00556	CbGeAlD
Clomipramine—HTR2C—telencephalon—germ cell cancer	0.000652	0.00538	CbGeAlD
Clomipramine—HRH2—endocrine gland—germ cell cancer	0.00065	0.00537	CbGeAlD
Clomipramine—HRH2—head—germ cell cancer	0.000642	0.0053	CbGeAlD
Clomipramine—GSTP1—gonad—germ cell cancer	0.00062	0.00511	CbGeAlD
Clomipramine—SLC6A4—telencephalon—germ cell cancer	0.000618	0.0051	CbGeAlD
Clomipramine—GSTP1—uterus—germ cell cancer	0.000615	0.00508	CbGeAlD
Clomipramine—SLC6A2—brainstem—germ cell cancer	0.000613	0.00506	CbGeAlD
Clomipramine—HTR2B—telencephalon—germ cell cancer	0.000612	0.00505	CbGeAlD
Clomipramine—GSTP1—pituitary gland—germ cell cancer	0.000604	0.00499	CbGeAlD
Clomipramine—HTR2B—skin of body—germ cell cancer	0.000584	0.00482	CbGeAlD
Clomipramine—GSTP1—medulla oblongata—germ cell cancer	0.000583	0.00482	CbGeAlD
Clomipramine—HTR2B—decidua—germ cell cancer	0.00058	0.00479	CbGeAlD
Clomipramine—SLC6A2—telencephalon—germ cell cancer	0.000544	0.00449	CbGeAlD
Clomipramine—GSTP1—adrenal gland—germ cell cancer	0.00054	0.00446	CbGeAlD
Clomipramine—GSTP1—midbrain—germ cell cancer	0.000533	0.0044	CbGeAlD
Clomipramine—GSTP1—bone marrow—germ cell cancer	0.000522	0.00431	CbGeAlD
Clomipramine—GSTP1—spinal cord—germ cell cancer	0.00052	0.00429	CbGeAlD
Clomipramine—SLC6A2—decidua—germ cell cancer	0.000515	0.00426	CbGeAlD
Clomipramine—HTR2C—medulla oblongata—germ cell cancer	0.000512	0.00423	CbGeAlD
Clomipramine—HTR6—brain—germ cell cancer	0.000509	0.0042	CbGeAlD
Clomipramine—HTR2B—uterus—germ cell cancer	0.000508	0.00419	CbGeAlD
Clomipramine—GSTP1—female gonad—germ cell cancer	0.000503	0.00416	CbGeAlD
Clomipramine—ADRA2A—trigeminal ganglion—germ cell cancer	0.000489	0.00404	CbGeAlD
Clomipramine—HTR2A—neck—germ cell cancer	0.000482	0.00398	CbGeAlD
Clomipramine—GSTP1—endocrine gland—germ cell cancer	0.000468	0.00387	CbGeAlD
Clomipramine—HTR2C—midbrain—germ cell cancer	0.000468	0.00386	CbGeAlD
Clomipramine—HRH2—brain—germ cell cancer	0.000465	0.00384	CbGeAlD
Clomipramine—ALB—adrenal gland—germ cell cancer	0.000462	0.00382	CbGeAlD
Clomipramine—GSTP1—head—germ cell cancer	0.000462	0.00382	CbGeAlD
Clomipramine—HTR2C—spinal cord—germ cell cancer	0.000457	0.00377	CbGeAlD
Clomipramine—SLC6A2—gonad—germ cell cancer	0.000454	0.00375	CbGeAlD
Clomipramine—HRH2—lymph node—germ cell cancer	0.00045	0.00371	CbGeAlD
Clomipramine—GSTP1—testis—germ cell cancer	0.000447	0.00369	CbGeAlD
Clomipramine—HTR2B—adrenal gland—germ cell cancer	0.000445	0.00368	CbGeAlD
Clomipramine—SLC6A4—midbrain—germ cell cancer	0.000444	0.00366	CbGeAlD
Clomipramine—ABCB1—blood vessel—germ cell cancer	0.000442	0.00365	CbGeAlD
Clomipramine—SLC6A4—spinal cord—germ cell cancer	0.000433	0.00357	CbGeAlD
Clomipramine—SLC6A2—medulla oblongata—germ cell cancer	0.000427	0.00353	CbGeAlD
Clomipramine—GSTP1—cerebellum—germ cell cancer	0.000412	0.0034	CbGeAlD
Clomipramine—HTR2C—head—germ cell cancer	0.000406	0.00335	CbGeAlD
Clomipramine—HTR2A—embryo—germ cell cancer	0.000402	0.00332	CbGeAlD
Clomipramine—SLC6A2—adrenal gland—germ cell cancer	0.000396	0.00327	CbGeAlD
Clomipramine—SLC6A4—endocrine gland—germ cell cancer	0.00039	0.00322	CbGeAlD
Clomipramine—SLC6A4—head—germ cell cancer	0.000385	0.00318	CbGeAlD
Clomipramine—ADRA2A—telencephalon—germ cell cancer	0.000384	0.00317	CbGeAlD
Clomipramine—ALB—testis—germ cell cancer	0.000382	0.00316	CbGeAlD
Clomipramine—HTR2B—head—germ cell cancer	0.000381	0.00315	CbGeAlD
Clomipramine—HTR2A—brainstem—germ cell cancer	0.000368	0.00304	CbGeAlD
Clomipramine—ADRA2A—decidua—germ cell cancer	0.000364	0.00301	CbGeAlD
Clomipramine—HTR2A—eye—germ cell cancer	0.000359	0.00296	CbGeAlD
Clomipramine—HTR2A—retina—germ cell cancer	0.000355	0.00293	CbGeAlD
Clomipramine—SLC6A2—endocrine gland—germ cell cancer	0.000343	0.00283	CbGeAlD
Clomipramine—SLC6A2—head—germ cell cancer	0.000339	0.0028	CbGeAlD
Clomipramine—CYP2D6—brainstem—germ cell cancer	0.000336	0.00277	CbGeAlD
Clomipramine—GSTP1—brain—germ cell cancer	0.000335	0.00277	CbGeAlD
Clomipramine—SLC6A2—testis—germ cell cancer	0.000327	0.0027	CbGeAlD
Clomipramine—HTR2A—telencephalon—germ cell cancer	0.000327	0.0027	CbGeAlD
Clomipramine—GSTP1—lymph node—germ cell cancer	0.000324	0.00267	CbGeAlD
Clomipramine—CYP2C19—endocrine gland—germ cell cancer	0.000323	0.00267	CbGeAlD
Clomipramine—ADRA2A—gonad—germ cell cancer	0.000321	0.00265	CbGeAlD
Clomipramine—ADRA2A—uterus—germ cell cancer	0.000319	0.00263	CbGeAlD
Clomipramine—ADRA2A—pituitary gland—germ cell cancer	0.000313	0.00258	CbGeAlD
Clomipramine—ADRA2A—medulla oblongata—germ cell cancer	0.000302	0.00249	CbGeAlD
Clomipramine—CYP2D6—telencephalon—germ cell cancer	0.000298	0.00246	CbGeAlD
Clomipramine—HTR2C—brain—germ cell cancer	0.000294	0.00243	CbGeAlD
Clomipramine—ALB—brain—germ cell cancer	0.000287	0.00237	CbGeAlD
Clomipramine—ADRA2A—adrenal gland—germ cell cancer	0.00028	0.00231	CbGeAlD
Clomipramine—SLC6A4—brain—germ cell cancer	0.000279	0.0023	CbGeAlD
Clomipramine—ALB—lymph node—germ cell cancer	0.000277	0.00229	CbGeAlD
Clomipramine—HTR2B—brain—germ cell cancer	0.000276	0.00228	CbGeAlD
Clomipramine—ADRA2A—midbrain—germ cell cancer	0.000276	0.00228	CbGeAlD
Clomipramine—HTR2A—gonad—germ cell cancer	0.000273	0.00225	CbGeAlD
Clomipramine—ABCB1—trigeminal ganglion—germ cell cancer	0.000273	0.00225	CbGeAlD
Clomipramine—ADRA2A—spinal cord—germ cell cancer	0.000269	0.00222	CbGeAlD
Clomipramine—HTR2B—lymph node—germ cell cancer	0.000267	0.0022	CbGeAlD
Clomipramine—HTR2A—pituitary gland—germ cell cancer	0.000266	0.0022	CbGeAlD
Clomipramine—CYP1A2—endocrine gland—germ cell cancer	0.000264	0.00218	CbGeAlD
Clomipramine—ABCB1—embryo—germ cell cancer	0.000263	0.00217	CbGeAlD
Clomipramine—ADRA2A—female gonad—germ cell cancer	0.000261	0.00215	CbGeAlD
Clomipramine—HTR2A—medulla oblongata—germ cell cancer	0.000257	0.00212	CbGeAlD
Clomipramine—SLC6A2—brain—germ cell cancer	0.000245	0.00203	CbGeAlD
Clomipramine—ADRA2A—endocrine gland—germ cell cancer	0.000242	0.002	CbGeAlD
Clomipramine—ADRA2A—head—germ cell cancer	0.000239	0.00198	CbGeAlD
Clomipramine—HTR2A—adrenal gland—germ cell cancer	0.000238	0.00196	CbGeAlD
Clomipramine—SLC6A2—lymph node—germ cell cancer	0.000237	0.00196	CbGeAlD
Clomipramine—HTR2A—midbrain—germ cell cancer	0.000235	0.00194	CbGeAlD
Clomipramine—ABCB1—retina—germ cell cancer	0.000233	0.00192	CbGeAlD
Clomipramine—Hypertension—Ifosfamide—germ cell cancer	0.000232	0.00128	CcSEcCtD
Clomipramine—Malnutrition—Cisplatin—germ cell cancer	0.000231	0.00128	CcSEcCtD
Clomipramine—ADRA2A—testis—germ cell cancer	0.000231	0.00191	CbGeAlD
Clomipramine—Paraesthesia—Bleomycin—germ cell cancer	0.00023	0.00128	CcSEcCtD
Clomipramine—HTR2A—spinal cord—germ cell cancer	0.000229	0.00189	CbGeAlD
Clomipramine—Dyspnoea—Bleomycin—germ cell cancer	0.000228	0.00127	CcSEcCtD
Clomipramine—Arthralgia—Ifosfamide—germ cell cancer	0.000228	0.00127	CcSEcCtD
Clomipramine—Chest pain—Ifosfamide—germ cell cancer	0.000228	0.00127	CcSEcCtD
Clomipramine—Myalgia—Ifosfamide—germ cell cancer	0.000228	0.00127	CcSEcCtD
Clomipramine—Flatulence—Cisplatin—germ cell cancer	0.000228	0.00126	CcSEcCtD
Clomipramine—Anorexia—Dactinomycin—germ cell cancer	0.000228	0.00126	CcSEcCtD
Clomipramine—Eye disorder—Etoposide—germ cell cancer	0.000228	0.00126	CcSEcCtD
Clomipramine—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.000227	0.00126	CcSEcCtD
Clomipramine—Cardiac disorder—Etoposide—germ cell cancer	0.000226	0.00125	CcSEcCtD
Clomipramine—Flushing—Etoposide—germ cell cancer	0.000226	0.00125	CcSEcCtD
Clomipramine—Discomfort—Ifosfamide—germ cell cancer	0.000226	0.00125	CcSEcCtD
Clomipramine—Hypersensitivity—Vinblastine—germ cell cancer	0.000224	0.00124	CcSEcCtD
Clomipramine—Decreased appetite—Bleomycin—germ cell cancer	0.000223	0.00123	CcSEcCtD
Clomipramine—Muscle spasms—Cisplatin—germ cell cancer	0.000222	0.00123	CcSEcCtD
Clomipramine—Angiopathy—Etoposide—germ cell cancer	0.000221	0.00122	CcSEcCtD
Clomipramine—Confusional state—Ifosfamide—germ cell cancer	0.000221	0.00122	CcSEcCtD
Clomipramine—Immune system disorder—Etoposide—germ cell cancer	0.00022	0.00122	CcSEcCtD
Clomipramine—Mediastinal disorder—Etoposide—germ cell cancer	0.000219	0.00122	CcSEcCtD
Clomipramine—Pain—Bleomycin—germ cell cancer	0.000219	0.00121	CcSEcCtD
Clomipramine—Anaphylactic shock—Ifosfamide—germ cell cancer	0.000219	0.00121	CcSEcCtD
Clomipramine—Oedema—Ifosfamide—germ cell cancer	0.000219	0.00121	CcSEcCtD
Clomipramine—Chills—Etoposide—germ cell cancer	0.000218	0.00121	CcSEcCtD
Clomipramine—Vision blurred—Cisplatin—germ cell cancer	0.000218	0.00121	CcSEcCtD
Clomipramine—Anaphylactoid reaction—Methotrexate—germ cell cancer	0.000218	0.00121	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.000218	0.00121	CcSEcCtD
Clomipramine—Asthenia—Vinblastine—germ cell cancer	0.000218	0.00121	CcSEcCtD
Clomipramine—Tremor—Cisplatin—germ cell cancer	0.000217	0.0012	CcSEcCtD
Clomipramine—Alopecia—Etoposide—germ cell cancer	0.000215	0.00119	CcSEcCtD
Clomipramine—Cerebrovascular accident—Methotrexate—germ cell cancer	0.000215	0.00119	CcSEcCtD
Clomipramine—Nervous system disorder—Ifosfamide—germ cell cancer	0.000215	0.00119	CcSEcCtD
Clomipramine—Ill-defined disorder—Cisplatin—germ cell cancer	0.000215	0.00119	CcSEcCtD
Clomipramine—Thrombocytopenia—Ifosfamide—germ cell cancer	0.000214	0.00119	CcSEcCtD
Clomipramine—ABCB1—telencephalon—germ cell cancer	0.000214	0.00177	CbGeAlD
Clomipramine—Anaemia—Cisplatin—germ cell cancer	0.000214	0.00119	CcSEcCtD
Clomipramine—ADRA2A—cerebellum—germ cell cancer	0.000214	0.00176	CbGeAlD
Clomipramine—Skin disorder—Ifosfamide—germ cell cancer	0.000213	0.00118	CcSEcCtD
Clomipramine—Hyperhidrosis—Ifosfamide—germ cell cancer	0.000212	0.00117	CcSEcCtD
Clomipramine—Feeling abnormal—Bleomycin—germ cell cancer	0.000211	0.00117	CcSEcCtD
Clomipramine—Osteoarthritis—Methotrexate—germ cell cancer	0.000211	0.00117	CcSEcCtD
Clomipramine—Desipramine—SLC22A3—germ cell cancer	0.00021	0.541	CrCbGaD
Clomipramine—Anorexia—Ifosfamide—germ cell cancer	0.000209	0.00116	CcSEcCtD
Clomipramine—Malaise—Cisplatin—germ cell cancer	0.000209	0.00116	CcSEcCtD
Clomipramine—Decreased appetite—Dactinomycin—germ cell cancer	0.000208	0.00115	CcSEcCtD
Clomipramine—Diarrhoea—Vinblastine—germ cell cancer	0.000208	0.00115	CcSEcCtD
Clomipramine—Dysgeusia—Etoposide—germ cell cancer	0.000208	0.00115	CcSEcCtD
Clomipramine—Leukopenia—Cisplatin—germ cell cancer	0.000207	0.00115	CcSEcCtD
Clomipramine—HTR2A—endocrine gland—germ cell cancer	0.000206	0.0017	CbGeAlD
Clomipramine—Fatigue—Dactinomycin—germ cell cancer	0.000206	0.00114	CcSEcCtD
Clomipramine—Back pain—Etoposide—germ cell cancer	0.000205	0.00114	CcSEcCtD
Clomipramine—Hypotension—Ifosfamide—germ cell cancer	0.000205	0.00113	CcSEcCtD
Clomipramine—Pain—Dactinomycin—germ cell cancer	0.000204	0.00113	CcSEcCtD
Clomipramine—Muscle spasms—Etoposide—germ cell cancer	0.000204	0.00113	CcSEcCtD
Clomipramine—Urticaria—Bleomycin—germ cell cancer	0.000204	0.00113	CcSEcCtD
Clomipramine—HTR2A—head—germ cell cancer	0.000204	0.00168	CbGeAlD
Clomipramine—ABCB1—decidua—germ cell cancer	0.000203	0.00168	CbGeAlD
Clomipramine—Body temperature increased—Bleomycin—germ cell cancer	0.000203	0.00112	CcSEcCtD
Clomipramine—CYP2D6—female gonad—germ cell cancer	0.000202	0.00167	CbGeAlD
Clomipramine—Irritability—Methotrexate—germ cell cancer	0.000201	0.00112	CcSEcCtD
Clomipramine—Dizziness—Vinblastine—germ cell cancer	0.000201	0.00111	CcSEcCtD
Clomipramine—Convulsion—Cisplatin—germ cell cancer	0.0002	0.00111	CcSEcCtD
Clomipramine—Mood swings—Methotrexate—germ cell cancer	0.0002	0.00111	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.0002	0.00111	CcSEcCtD
Clomipramine—Ataxia—Methotrexate—germ cell cancer	0.000198	0.0011	CcSEcCtD
Clomipramine—Myalgia—Cisplatin—germ cell cancer	0.000197	0.00109	CcSEcCtD
Clomipramine—Feeling abnormal—Dactinomycin—germ cell cancer	0.000197	0.00109	CcSEcCtD
Clomipramine—Paraesthesia—Ifosfamide—germ cell cancer	0.000197	0.00109	CcSEcCtD
Clomipramine—Ill-defined disorder—Etoposide—germ cell cancer	0.000197	0.00109	CcSEcCtD
Clomipramine—HTR2A—testis—germ cell cancer	0.000197	0.00162	CbGeAlD
Clomipramine—Anxiety—Cisplatin—germ cell cancer	0.000196	0.00109	CcSEcCtD
Clomipramine—Anaemia—Etoposide—germ cell cancer	0.000196	0.00109	CcSEcCtD
Clomipramine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.000196	0.00108	CcSEcCtD
Clomipramine—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000195	0.00108	CcSEcCtD
Clomipramine—Dyspnoea—Ifosfamide—germ cell cancer	0.000195	0.00108	CcSEcCtD
Clomipramine—Somnolence—Ifosfamide—germ cell cancer	0.000195	0.00108	CcSEcCtD
Clomipramine—Discomfort—Cisplatin—germ cell cancer	0.000195	0.00108	CcSEcCtD
Clomipramine—ABCB1—Abacavir transmembrane transport—SLC22A3—germ cell cancer	0.000194	0.0789	CbGpPWpGaD
Clomipramine—Vomiting—Vinblastine—germ cell cancer	0.000193	0.00107	CcSEcCtD
Clomipramine—Malaise—Etoposide—germ cell cancer	0.000191	0.00106	CcSEcCtD
Clomipramine—CYP3A4—endocrine gland—germ cell cancer	0.000191	0.00158	CbGeAlD
Clomipramine—Breast disorder—Methotrexate—germ cell cancer	0.000191	0.00106	CcSEcCtD
Clomipramine—Vertigo—Etoposide—germ cell cancer	0.00019	0.00106	CcSEcCtD
Clomipramine—Decreased appetite—Ifosfamide—germ cell cancer	0.00019	0.00106	CcSEcCtD
Clomipramine—Headache—Vinblastine—germ cell cancer	0.00019	0.00105	CcSEcCtD
Clomipramine—Leukopenia—Etoposide—germ cell cancer	0.00019	0.00105	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000189	0.00105	CcSEcCtD
Clomipramine—Body temperature increased—Dactinomycin—germ cell cancer	0.000189	0.00105	CcSEcCtD
Clomipramine—Abdominal pain—Dactinomycin—germ cell cancer	0.000189	0.00105	CcSEcCtD
Clomipramine—Fatigue—Ifosfamide—germ cell cancer	0.000189	0.00105	CcSEcCtD
Clomipramine—Anaphylactic shock—Cisplatin—germ cell cancer	0.000189	0.00105	CcSEcCtD
Clomipramine—Oedema—Cisplatin—germ cell cancer	0.000189	0.00105	CcSEcCtD
Clomipramine—Hypersensitivity—Bleomycin—germ cell cancer	0.000189	0.00105	CcSEcCtD
Clomipramine—CYP2D6—endocrine gland—germ cell cancer	0.000188	0.00155	CbGeAlD
Clomipramine—Pain—Ifosfamide—germ cell cancer	0.000187	0.00104	CcSEcCtD
Clomipramine—Constipation—Ifosfamide—germ cell cancer	0.000187	0.00104	CcSEcCtD
Clomipramine—Loss of consciousness—Etoposide—germ cell cancer	0.000186	0.00103	CcSEcCtD
Clomipramine—CYP2D6—head—germ cell cancer	0.000185	0.00153	CbGeAlD
Clomipramine—Nervous system disorder—Cisplatin—germ cell cancer	0.000185	0.00103	CcSEcCtD
Clomipramine—Cough—Etoposide—germ cell cancer	0.000185	0.00103	CcSEcCtD
Clomipramine—Thrombocytopenia—Cisplatin—germ cell cancer	0.000185	0.00102	CcSEcCtD
Clomipramine—Tachycardia—Cisplatin—germ cell cancer	0.000184	0.00102	CcSEcCtD
Clomipramine—Asthenia—Bleomycin—germ cell cancer	0.000184	0.00102	CcSEcCtD
Clomipramine—Convulsion—Etoposide—germ cell cancer	0.000184	0.00102	CcSEcCtD
Clomipramine—Skin disorder—Cisplatin—germ cell cancer	0.000183	0.00102	CcSEcCtD
Clomipramine—GSTP1—Metapathway biotransformation—NAT9—germ cell cancer	0.000183	0.0744	CbGpPWpGaD
Clomipramine—Hypertension—Etoposide—germ cell cancer	0.000183	0.00101	CcSEcCtD
Clomipramine—Hyperhidrosis—Cisplatin—germ cell cancer	0.000183	0.00101	CcSEcCtD
Clomipramine—HTR2A—cerebellum—germ cell cancer	0.000182	0.0015	CbGeAlD
Clomipramine—Pruritus—Bleomycin—germ cell cancer	0.000181	0.00101	CcSEcCtD
Clomipramine—Feeling abnormal—Ifosfamide—germ cell cancer	0.000181	0.001	CcSEcCtD
Clomipramine—Chest pain—Etoposide—germ cell cancer	0.00018	0.001	CcSEcCtD
Clomipramine—Eosinophilia—Methotrexate—germ cell cancer	0.00018	0.001	CcSEcCtD
Clomipramine—Nausea—Vinblastine—germ cell cancer	0.00018	0.000999	CcSEcCtD
Clomipramine—Anorexia—Cisplatin—germ cell cancer	0.00018	0.000998	CcSEcCtD
Clomipramine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.000179	0.000993	CcSEcCtD
Clomipramine—CYP2D6—testis—germ cell cancer	0.000179	0.00148	CbGeAlD
Clomipramine—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000179	0.000993	CcSEcCtD
Clomipramine—ABCB1—gonad—germ cell cancer	0.000179	0.00148	CbGeAlD
Clomipramine—Discomfort—Etoposide—germ cell cancer	0.000178	0.000988	CcSEcCtD
Clomipramine—Imipramine—SLC22A3—germ cell cancer	0.000178	0.459	CrCbGaD
Clomipramine—ABCB1—uterus—germ cell cancer	0.000178	0.00147	CbGeAlD
Clomipramine—Hypotension—Cisplatin—germ cell cancer	0.000176	0.000978	CcSEcCtD
Clomipramine—Hypersensitivity—Dactinomycin—germ cell cancer	0.000176	0.000976	CcSEcCtD
Clomipramine—Confusional state—Etoposide—germ cell cancer	0.000174	0.000967	CcSEcCtD
Clomipramine—ABCB1—pituitary gland—germ cell cancer	0.000174	0.00144	CbGeAlD
Clomipramine—Urticaria—Ifosfamide—germ cell cancer	0.000174	0.000964	CcSEcCtD
Clomipramine—ADRA2A—brain—germ cell cancer	0.000173	0.00143	CbGeAlD
Clomipramine—Body temperature increased—Ifosfamide—germ cell cancer	0.000173	0.00096	CcSEcCtD
Clomipramine—Abdominal pain—Ifosfamide—germ cell cancer	0.000173	0.00096	CcSEcCtD
Clomipramine—Pancytopenia—Methotrexate—germ cell cancer	0.000173	0.000959	CcSEcCtD
Clomipramine—Anaphylactic shock—Etoposide—germ cell cancer	0.000173	0.000959	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.000172	0.000954	CcSEcCtD
Clomipramine—Asthenia—Dactinomycin—germ cell cancer	0.000171	0.000951	CcSEcCtD
Clomipramine—Dysuria—Methotrexate—germ cell cancer	0.00017	0.000944	CcSEcCtD
Clomipramine—Paraesthesia—Cisplatin—germ cell cancer	0.00017	0.00094	CcSEcCtD
Clomipramine—Thrombocytopenia—Etoposide—germ cell cancer	0.000169	0.000939	CcSEcCtD
Clomipramine—Tachycardia—Etoposide—germ cell cancer	0.000169	0.000936	CcSEcCtD
Clomipramine—Dyspnoea—Cisplatin—germ cell cancer	0.000168	0.000933	CcSEcCtD
Clomipramine—ABCB1—medulla oblongata—germ cell cancer	0.000168	0.00139	CbGeAlD
Clomipramine—Skin disorder—Etoposide—germ cell cancer	0.000168	0.000931	CcSEcCtD
Clomipramine—Erectile dysfunction—Methotrexate—germ cell cancer	0.000168	0.00093	CcSEcCtD
Clomipramine—ADRA2A—lymph node—germ cell cancer	0.000168	0.00138	CbGeAlD
Clomipramine—Hyperhidrosis—Etoposide—germ cell cancer	0.000167	0.000927	CcSEcCtD
Clomipramine—Photosensitivity reaction—Methotrexate—germ cell cancer	0.000166	0.000922	CcSEcCtD
Clomipramine—CYP2D6—cerebellum—germ cell cancer	0.000165	0.00137	CbGeAlD
Clomipramine—Anorexia—Etoposide—germ cell cancer	0.000165	0.000914	CcSEcCtD
Clomipramine—Decreased appetite—Cisplatin—germ cell cancer	0.000164	0.00091	CcSEcCtD
Clomipramine—Diarrhoea—Dactinomycin—germ cell cancer	0.000164	0.000906	CcSEcCtD
Clomipramine—Pneumonia—Methotrexate—germ cell cancer	0.000163	0.000906	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.000163	0.000904	CcSEcCtD
Clomipramine—Vomiting—Bleomycin—germ cell cancer	0.000163	0.000903	CcSEcCtD
Clomipramine—Drowsiness—Methotrexate—germ cell cancer	0.000162	0.000901	CcSEcCtD
Clomipramine—Depression—Methotrexate—germ cell cancer	0.000162	0.000898	CcSEcCtD
Clomipramine—Hypotension—Etoposide—germ cell cancer	0.000162	0.000896	CcSEcCtD
Clomipramine—Rash—Bleomycin—germ cell cancer	0.000162	0.000896	CcSEcCtD
Clomipramine—Pain—Cisplatin—germ cell cancer	0.000161	0.000895	CcSEcCtD
Clomipramine—Dermatitis—Bleomycin—germ cell cancer	0.000161	0.000895	CcSEcCtD
Clomipramine—Hypersensitivity—Ifosfamide—germ cell cancer	0.000161	0.000894	CcSEcCtD
Clomipramine—Conjunctivitis—Methotrexate—germ cell cancer	0.000158	0.000875	CcSEcCtD
Clomipramine—Asthenia—Ifosfamide—germ cell cancer	0.000157	0.000871	CcSEcCtD
Clomipramine—ABCB1—adrenal gland—germ cell cancer	0.000156	0.00129	CbGeAlD
Clomipramine—Sweating—Methotrexate—germ cell cancer	0.000156	0.000863	CcSEcCtD
Clomipramine—Feeling abnormal—Cisplatin—germ cell cancer	0.000156	0.000862	CcSEcCtD
Clomipramine—Paraesthesia—Etoposide—germ cell cancer	0.000155	0.000861	CcSEcCtD
Clomipramine—Pruritus—Ifosfamide—germ cell cancer	0.000155	0.000859	CcSEcCtD
Clomipramine—Haematuria—Methotrexate—germ cell cancer	0.000155	0.000859	CcSEcCtD
Clomipramine—Dyspnoea—Etoposide—germ cell cancer	0.000154	0.000855	CcSEcCtD
Clomipramine—ABCB1—midbrain—germ cell cancer	0.000154	0.00127	CbGeAlD
Clomipramine—Somnolence—Etoposide—germ cell cancer	0.000154	0.000852	CcSEcCtD
Clomipramine—Hepatobiliary disease—Methotrexate—germ cell cancer	0.000154	0.000852	CcSEcCtD
Clomipramine—Epistaxis—Methotrexate—germ cell cancer	0.000153	0.000849	CcSEcCtD
Clomipramine—Nausea—Bleomycin—germ cell cancer	0.000152	0.000844	CcSEcCtD
Clomipramine—Vomiting—Dactinomycin—germ cell cancer	0.000152	0.000842	CcSEcCtD
Clomipramine—Agranulocytosis—Methotrexate—germ cell cancer	0.000152	0.00084	CcSEcCtD
Clomipramine—ABCB1—bone marrow—germ cell cancer	0.000151	0.00124	CbGeAlD
Clomipramine—Rash—Dactinomycin—germ cell cancer	0.000151	0.000835	CcSEcCtD
Clomipramine—Decreased appetite—Etoposide—germ cell cancer	0.00015	0.000834	CcSEcCtD
Clomipramine—ABCB1—spinal cord—germ cell cancer	0.00015	0.00124	CbGeAlD
Clomipramine—Diarrhoea—Ifosfamide—germ cell cancer	0.00015	0.000831	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Etoposide—germ cell cancer	0.000149	0.000828	CcSEcCtD
Clomipramine—Body temperature increased—Cisplatin—germ cell cancer	0.000149	0.000827	CcSEcCtD
Clomipramine—Fatigue—Etoposide—germ cell cancer	0.000149	0.000827	CcSEcCtD
Clomipramine—Pain—Etoposide—germ cell cancer	0.000148	0.00082	CcSEcCtD
Clomipramine—Constipation—Etoposide—germ cell cancer	0.000148	0.00082	CcSEcCtD
Clomipramine—HTR2A—brain—germ cell cancer	0.000147	0.00122	CbGeAlD
Clomipramine—Hepatitis—Methotrexate—germ cell cancer	0.000146	0.000808	CcSEcCtD
Clomipramine—ABCB1—female gonad—germ cell cancer	0.000145	0.0012	CbGeAlD
Clomipramine—Dizziness—Ifosfamide—germ cell cancer	0.000145	0.000803	CcSEcCtD
Clomipramine—Pharyngitis—Methotrexate—germ cell cancer	0.000145	0.000802	CcSEcCtD
Clomipramine—Urinary tract disorder—Methotrexate—germ cell cancer	0.000144	0.000798	CcSEcCtD
Clomipramine—Urethral disorder—Methotrexate—germ cell cancer	0.000143	0.000792	CcSEcCtD
Clomipramine—Feeling abnormal—Etoposide—germ cell cancer	0.000143	0.00079	CcSEcCtD
Clomipramine—Nausea—Dactinomycin—germ cell cancer	0.000142	0.000787	CcSEcCtD
Clomipramine—Gastrointestinal pain—Etoposide—germ cell cancer	0.000141	0.000784	CcSEcCtD
Clomipramine—Visual impairment—Methotrexate—germ cell cancer	0.000141	0.000779	CcSEcCtD
Clomipramine—Vomiting—Ifosfamide—germ cell cancer	0.000139	0.000772	CcSEcCtD
Clomipramine—Hypersensitivity—Cisplatin—germ cell cancer	0.000139	0.000771	CcSEcCtD
Clomipramine—Rash—Ifosfamide—germ cell cancer	0.000138	0.000765	CcSEcCtD
Clomipramine—Dermatitis—Ifosfamide—germ cell cancer	0.000138	0.000765	CcSEcCtD
Clomipramine—Urticaria—Etoposide—germ cell cancer	0.000137	0.000762	CcSEcCtD
Clomipramine—Body temperature increased—Etoposide—germ cell cancer	0.000137	0.000758	CcSEcCtD
Clomipramine—Abdominal pain—Etoposide—germ cell cancer	0.000137	0.000758	CcSEcCtD
Clomipramine—Eye disorder—Methotrexate—germ cell cancer	0.000136	0.000755	CcSEcCtD
Clomipramine—Tinnitus—Methotrexate—germ cell cancer	0.000136	0.000754	CcSEcCtD
Clomipramine—Asthenia—Cisplatin—germ cell cancer	0.000135	0.000751	CcSEcCtD
Clomipramine—Cardiac disorder—Methotrexate—germ cell cancer	0.000135	0.00075	CcSEcCtD
Clomipramine—ABCB1—endocrine gland—germ cell cancer	0.000135	0.00112	CbGeAlD
Clomipramine—CYP2D6—brain—germ cell cancer	0.000134	0.00111	CbGeAlD
Clomipramine—ABCB1—head—germ cell cancer	0.000133	0.0011	CbGeAlD
Clomipramine—Angiopathy—Methotrexate—germ cell cancer	0.000132	0.000733	CcSEcCtD
Clomipramine—Immune system disorder—Methotrexate—germ cell cancer	0.000132	0.00073	CcSEcCtD
Clomipramine—Mediastinal disorder—Methotrexate—germ cell cancer	0.000131	0.000729	CcSEcCtD
Clomipramine—Chills—Methotrexate—germ cell cancer	0.000131	0.000725	CcSEcCtD
Clomipramine—Nausea—Ifosfamide—germ cell cancer	0.00013	0.000721	CcSEcCtD
Clomipramine—Diarrhoea—Cisplatin—germ cell cancer	0.000129	0.000716	CcSEcCtD
Clomipramine—Alopecia—Methotrexate—germ cell cancer	0.000129	0.000714	CcSEcCtD
Clomipramine—ABCB1—testis—germ cell cancer	0.000129	0.00106	CbGeAlD
Clomipramine—Mental disorder—Methotrexate—germ cell cancer	0.000128	0.000708	CcSEcCtD
Clomipramine—Hypersensitivity—Etoposide—germ cell cancer	0.000127	0.000706	CcSEcCtD
Clomipramine—Malnutrition—Methotrexate—germ cell cancer	0.000127	0.000704	CcSEcCtD
Clomipramine—Dysgeusia—Methotrexate—germ cell cancer	0.000124	0.000689	CcSEcCtD
Clomipramine—Asthenia—Etoposide—germ cell cancer	0.000124	0.000688	CcSEcCtD
Clomipramine—Back pain—Methotrexate—germ cell cancer	0.000123	0.000681	CcSEcCtD
Clomipramine—Pruritus—Etoposide—germ cell cancer	0.000122	0.000678	CcSEcCtD
Clomipramine—Vomiting—Cisplatin—germ cell cancer	0.00012	0.000665	CcSEcCtD
Clomipramine—Vision blurred—Methotrexate—germ cell cancer	0.00012	0.000663	CcSEcCtD
Clomipramine—Rash—Cisplatin—germ cell cancer	0.000119	0.00066	CcSEcCtD
Clomipramine—ABCB1—cerebellum—germ cell cancer	0.000119	0.000982	CbGeAlD
Clomipramine—Dermatitis—Cisplatin—germ cell cancer	0.000119	0.000659	CcSEcCtD
Clomipramine—Diarrhoea—Etoposide—germ cell cancer	0.000118	0.000656	CcSEcCtD
Clomipramine—Ill-defined disorder—Methotrexate—germ cell cancer	0.000118	0.000653	CcSEcCtD
Clomipramine—Anaemia—Methotrexate—germ cell cancer	0.000117	0.00065	CcSEcCtD
Clomipramine—Malaise—Methotrexate—germ cell cancer	0.000114	0.000635	CcSEcCtD
Clomipramine—Dizziness—Etoposide—germ cell cancer	0.000114	0.000634	CcSEcCtD
Clomipramine—Vertigo—Methotrexate—germ cell cancer	0.000114	0.000632	CcSEcCtD
Clomipramine—Leukopenia—Methotrexate—germ cell cancer	0.000114	0.00063	CcSEcCtD
Clomipramine—Nausea—Cisplatin—germ cell cancer	0.000112	0.000622	CcSEcCtD
Clomipramine—ABCB1—Abacavir transport and metabolism—SLC22A3—germ cell cancer	0.000112	0.0453	CbGpPWpGaD
Clomipramine—Cough—Methotrexate—germ cell cancer	0.000111	0.000614	CcSEcCtD
Clomipramine—Convulsion—Methotrexate—germ cell cancer	0.00011	0.00061	CcSEcCtD
Clomipramine—Vomiting—Etoposide—germ cell cancer	0.00011	0.00061	CcSEcCtD
Clomipramine—Rash—Etoposide—germ cell cancer	0.000109	0.000605	CcSEcCtD
Clomipramine—Dermatitis—Etoposide—germ cell cancer	0.000109	0.000604	CcSEcCtD
Clomipramine—Headache—Etoposide—germ cell cancer	0.000108	0.000601	CcSEcCtD
Clomipramine—Myalgia—Methotrexate—germ cell cancer	0.000108	0.000599	CcSEcCtD
Clomipramine—Chest pain—Methotrexate—germ cell cancer	0.000108	0.000599	CcSEcCtD
Clomipramine—Arthralgia—Methotrexate—germ cell cancer	0.000108	0.000599	CcSEcCtD
Clomipramine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.000107	0.000595	CcSEcCtD
Clomipramine—SLC6A4—Monoamine Transport—PVRL2—germ cell cancer	0.000107	0.0435	CbGpPWpGaD
Clomipramine—Discomfort—Methotrexate—germ cell cancer	0.000107	0.000592	CcSEcCtD
Clomipramine—Confusional state—Methotrexate—germ cell cancer	0.000104	0.000579	CcSEcCtD
Clomipramine—Anaphylactic shock—Methotrexate—germ cell cancer	0.000104	0.000574	CcSEcCtD
Clomipramine—Nausea—Etoposide—germ cell cancer	0.000103	0.00057	CcSEcCtD
Clomipramine—Nervous system disorder—Methotrexate—germ cell cancer	0.000102	0.000563	CcSEcCtD
Clomipramine—Thrombocytopenia—Methotrexate—germ cell cancer	0.000101	0.000562	CcSEcCtD
Clomipramine—Skin disorder—Methotrexate—germ cell cancer	0.000101	0.000558	CcSEcCtD
Clomipramine—Hyperhidrosis—Methotrexate—germ cell cancer	0.0001	0.000555	CcSEcCtD
Clomipramine—Anorexia—Methotrexate—germ cell cancer	9.88e-05	0.000547	CcSEcCtD
Clomipramine—Hypotension—Methotrexate—germ cell cancer	9.68e-05	0.000537	CcSEcCtD
Clomipramine—ABCB1—brain—germ cell cancer	9.67e-05	0.000798	CbGeAlD
Clomipramine—Musculoskeletal discomfort—Methotrexate—germ cell cancer	9.44e-05	0.000523	CcSEcCtD
Clomipramine—Insomnia—Methotrexate—germ cell cancer	9.37e-05	0.000519	CcSEcCtD
Clomipramine—ABCB1—lymph node—germ cell cancer	9.34e-05	0.000771	CbGeAlD
Clomipramine—Paraesthesia—Methotrexate—germ cell cancer	9.3e-05	0.000516	CcSEcCtD
Clomipramine—Dyspnoea—Methotrexate—germ cell cancer	9.24e-05	0.000512	CcSEcCtD
Clomipramine—SLC6A2—Monoamine Transport—PVRL2—germ cell cancer	9.22e-05	0.0374	CbGpPWpGaD
Clomipramine—Somnolence—Methotrexate—germ cell cancer	9.21e-05	0.000511	CcSEcCtD
Clomipramine—Dyspepsia—Methotrexate—germ cell cancer	9.12e-05	0.000506	CcSEcCtD
Clomipramine—Decreased appetite—Methotrexate—germ cell cancer	9.01e-05	0.000499	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Methotrexate—germ cell cancer	8.95e-05	0.000496	CcSEcCtD
Clomipramine—Fatigue—Methotrexate—germ cell cancer	8.93e-05	0.000495	CcSEcCtD
Clomipramine—Pain—Methotrexate—germ cell cancer	8.86e-05	0.000491	CcSEcCtD
Clomipramine—Feeling abnormal—Methotrexate—germ cell cancer	8.54e-05	0.000473	CcSEcCtD
Clomipramine—GSTP1—Cellular responses to stress—PHC1—germ cell cancer	8.5e-05	0.0345	CbGpPWpGaD
Clomipramine—Gastrointestinal pain—Methotrexate—germ cell cancer	8.47e-05	0.00047	CcSEcCtD
Clomipramine—Urticaria—Methotrexate—germ cell cancer	8.23e-05	0.000456	CcSEcCtD
Clomipramine—Abdominal pain—Methotrexate—germ cell cancer	8.19e-05	0.000454	CcSEcCtD
Clomipramine—Body temperature increased—Methotrexate—germ cell cancer	8.19e-05	0.000454	CcSEcCtD
Clomipramine—SLC6A4—Synaptic Vesicle Pathway—SLC22A3—germ cell cancer	8e-05	0.0325	CbGpPWpGaD
Clomipramine—Hypersensitivity—Methotrexate—germ cell cancer	7.63e-05	0.000423	CcSEcCtD
Clomipramine—Asthenia—Methotrexate—germ cell cancer	7.43e-05	0.000412	CcSEcCtD
Clomipramine—Pruritus—Methotrexate—germ cell cancer	7.33e-05	0.000406	CcSEcCtD
Clomipramine—Diarrhoea—Methotrexate—germ cell cancer	7.09e-05	0.000393	CcSEcCtD
Clomipramine—Dizziness—Methotrexate—germ cell cancer	6.85e-05	0.00038	CcSEcCtD
Clomipramine—Vomiting—Methotrexate—germ cell cancer	6.59e-05	0.000365	CcSEcCtD
Clomipramine—Rash—Methotrexate—germ cell cancer	6.53e-05	0.000362	CcSEcCtD
Clomipramine—Dermatitis—Methotrexate—germ cell cancer	6.53e-05	0.000362	CcSEcCtD
Clomipramine—Headache—Methotrexate—germ cell cancer	6.49e-05	0.00036	CcSEcCtD
Clomipramine—Nausea—Methotrexate—germ cell cancer	6.16e-05	0.000341	CcSEcCtD
Clomipramine—GSTP1—NRF2 pathway—SLC2A3—germ cell cancer	5.76e-05	0.0234	CbGpPWpGaD
Clomipramine—ALB—Transport of organic anions—AVP—germ cell cancer	5.52e-05	0.0224	CbGpPWpGaD
Clomipramine—SLC6A4—SIDS Susceptibility Pathways—NANOG—germ cell cancer	4.87e-05	0.0198	CbGpPWpGaD
Clomipramine—SLC6A4—SIDS Susceptibility Pathways—POU5F1—germ cell cancer	4.69e-05	0.019	CbGpPWpGaD
Clomipramine—CYP2C19—Metapathway biotransformation—NAT9—germ cell cancer	4.33e-05	0.0176	CbGpPWpGaD
Clomipramine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	4.18e-05	0.017	CbGpPWpGaD
Clomipramine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	4.11e-05	0.0167	CbGpPWpGaD
Clomipramine—CYP2D6—Metapathway biotransformation—NAT9—germ cell cancer	3.98e-05	0.0162	CbGpPWpGaD
Clomipramine—SLC6A4—NRF2 pathway—SLC2A3—germ cell cancer	3.5e-05	0.0142	CbGpPWpGaD
Clomipramine—CYP1A2—Metapathway biotransformation—NAT9—germ cell cancer	3.37e-05	0.0137	CbGpPWpGaD
Clomipramine—SLC6A2—NRF2 pathway—SLC2A3—germ cell cancer	3.01e-05	0.0122	CbGpPWpGaD
Clomipramine—HTR2A—SIDS Susceptibility Pathways—NANOG—germ cell cancer	2.93e-05	0.0119	CbGpPWpGaD
Clomipramine—HTR2A—SIDS Susceptibility Pathways—POU5F1—germ cell cancer	2.82e-05	0.0114	CbGpPWpGaD
Clomipramine—CYP3A4—Metapathway biotransformation—NAT9—germ cell cancer	2.6e-05	0.0106	CbGpPWpGaD
Clomipramine—SLC6A4—SIDS Susceptibility Pathways—SOX2—germ cell cancer	2.6e-05	0.0106	CbGpPWpGaD
Clomipramine—ALB—Platelet degranulation—CD9—germ cell cancer	2.38e-05	0.00965	CbGpPWpGaD
Clomipramine—ALB—Response to elevated platelet cytosolic Ca2+—CD9—germ cell cancer	2.26e-05	0.0092	CbGpPWpGaD
Clomipramine—HRH2—G alpha (s) signalling events—AVP—germ cell cancer	2.26e-05	0.00917	CbGpPWpGaD
Clomipramine—HTR2B—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—HRAS—germ cell cancer	2.05e-05	0.00834	CbGpPWpGaD
Clomipramine—ALB—Transport of vitamins, nucleosides, and related molecules—AVP—germ cell cancer	2.05e-05	0.00832	CbGpPWpGaD
Clomipramine—SLC6A2—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	1.9e-05	0.00771	CbGpPWpGaD
Clomipramine—SLC6A2—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	1.87e-05	0.00759	CbGpPWpGaD
Clomipramine—GSTP1—Cellular responses to stress—H2AFZ—germ cell cancer	1.84e-05	0.00747	CbGpPWpGaD
Clomipramine—HTR6—G alpha (s) signalling events—AVP—germ cell cancer	1.73e-05	0.00703	CbGpPWpGaD
Clomipramine—HTR2B—G alpha (q) signalling events—OXT—germ cell cancer	1.66e-05	0.00674	CbGpPWpGaD
Clomipramine—HTR2C—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—HRAS—germ cell cancer	1.66e-05	0.00673	CbGpPWpGaD
Clomipramine—HRH2—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	1.57e-05	0.00638	CbGpPWpGaD
Clomipramine—HTR2A—SIDS Susceptibility Pathways—SOX2—germ cell cancer	1.56e-05	0.00635	CbGpPWpGaD
Clomipramine—SLC6A4—SIDS Susceptibility Pathways—AVP—germ cell cancer	1.53e-05	0.00622	CbGpPWpGaD
Clomipramine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—OXT—germ cell cancer	1.49e-05	0.00603	CbGpPWpGaD
Clomipramine—SLC6A2—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	1.47e-05	0.00599	CbGpPWpGaD
Clomipramine—HTR2A—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—HRAS—germ cell cancer	1.44e-05	0.00584	CbGpPWpGaD
Clomipramine—HTR2C—G alpha (q) signalling events—OXT—germ cell cancer	1.34e-05	0.00544	CbGpPWpGaD
Clomipramine—ADRA2A—Platelet activation, signaling and aggregation—CD9—germ cell cancer	1.34e-05	0.00543	CbGpPWpGaD
Clomipramine—SLC6A4—Circadian rythm related genes—AVP—germ cell cancer	1.25e-05	0.00508	CbGpPWpGaD
Clomipramine—HTR6—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	1.21e-05	0.00489	CbGpPWpGaD
Clomipramine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—OXT—germ cell cancer	1.2e-05	0.00487	CbGpPWpGaD
Clomipramine—HRH2—GPCR ligand binding—OXT—germ cell cancer	1.2e-05	0.00486	CbGpPWpGaD
Clomipramine—HTR2A—G alpha (q) signalling events—OXT—germ cell cancer	1.16e-05	0.00472	CbGpPWpGaD
Clomipramine—HTR2B—G alpha (q) signalling events—AVP—germ cell cancer	1.14e-05	0.00462	CbGpPWpGaD
Clomipramine—HTR2B—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	1.1e-05	0.00447	CbGpPWpGaD
Clomipramine—HRH2—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	1.08e-05	0.00437	CbGpPWpGaD
Clomipramine—ALB—Platelet activation, signaling and aggregation—CD9—germ cell cancer	1.05e-05	0.00428	CbGpPWpGaD
Clomipramine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—OXT—germ cell cancer	1.04e-05	0.00423	CbGpPWpGaD
Clomipramine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—germ cell cancer	1.02e-05	0.00415	CbGpPWpGaD
Clomipramine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—germ cell cancer	1.02e-05	0.00413	CbGpPWpGaD
Clomipramine—SLC6A2—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	9.64e-06	0.00392	CbGpPWpGaD
Clomipramine—ALB—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	9.54e-06	0.00387	CbGpPWpGaD
Clomipramine—SLC6A2—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	9.5e-06	0.00386	CbGpPWpGaD
Clomipramine—ALB—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	9.4e-06	0.00381	CbGpPWpGaD
Clomipramine—HTR2A—SIDS Susceptibility Pathways—AVP—germ cell cancer	9.22e-06	0.00374	CbGpPWpGaD
Clomipramine—HTR2C—G alpha (q) signalling events—AVP—germ cell cancer	9.18e-06	0.00373	CbGpPWpGaD
Clomipramine—HTR6—GPCR ligand binding—OXT—germ cell cancer	9.18e-06	0.00373	CbGpPWpGaD
Clomipramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	8.87e-06	0.0036	CbGpPWpGaD
Clomipramine—SLC6A2—SLC-mediated transmembrane transport—AVP—germ cell cancer	8.75e-06	0.00355	CbGpPWpGaD
Clomipramine—GSTP1—Metabolism—SLC2A3—germ cell cancer	8.64e-06	0.00351	CbGpPWpGaD
Clomipramine—GSTP1—Metabolism—SLC22A3—germ cell cancer	8.51e-06	0.00345	CbGpPWpGaD
Clomipramine—HTR2B—GPCR ligand binding—OXT—germ cell cancer	8.38e-06	0.0034	CbGpPWpGaD
Clomipramine—HTR6—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	8.26e-06	0.00335	CbGpPWpGaD
Clomipramine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—germ cell cancer	8.21e-06	0.00333	CbGpPWpGaD
Clomipramine—HRH2—GPCR ligand binding—AVP—germ cell cancer	8.2e-06	0.00333	CbGpPWpGaD
Clomipramine—HTR2A—G alpha (q) signalling events—AVP—germ cell cancer	7.98e-06	0.00324	CbGpPWpGaD
Clomipramine—HTR2A—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	7.71e-06	0.00313	CbGpPWpGaD
Clomipramine—HTR2B—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	7.54e-06	0.00306	CbGpPWpGaD
Clomipramine—ALB—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	7.41e-06	0.00301	CbGpPWpGaD
Clomipramine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—germ cell cancer	7.13e-06	0.0029	CbGpPWpGaD
Clomipramine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	7.01e-06	0.00285	CbGpPWpGaD
Clomipramine—GSTP1—Metabolism—CRABP1—germ cell cancer	6.94e-06	0.00282	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—CD9—germ cell cancer	6.89e-06	0.0028	CbGpPWpGaD
Clomipramine—HRH2—GPCR downstream signaling—OXT—germ cell cancer	6.76e-06	0.00275	CbGpPWpGaD
Clomipramine—HTR2C—GPCR ligand binding—OXT—germ cell cancer	6.76e-06	0.00274	CbGpPWpGaD
Clomipramine—ABCB1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	6.49e-06	0.00264	CbGpPWpGaD
Clomipramine—HTR6—GPCR ligand binding—AVP—germ cell cancer	6.29e-06	0.00255	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—OXT—germ cell cancer	6.14e-06	0.00249	CbGpPWpGaD
Clomipramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	6.08e-06	0.00247	CbGpPWpGaD
Clomipramine—HTR2A—GPCR ligand binding—OXT—germ cell cancer	5.87e-06	0.00238	CbGpPWpGaD
Clomipramine—HTR2B—GPCR ligand binding—AVP—germ cell cancer	5.74e-06	0.00233	CbGpPWpGaD
Clomipramine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—germ cell cancer	5.63e-06	0.00228	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—CD9—germ cell cancer	5.44e-06	0.00221	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR ligand binding—OXT—germ cell cancer	5.34e-06	0.00217	CbGpPWpGaD
Clomipramine—HTR2A—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	5.28e-06	0.00214	CbGpPWpGaD
Clomipramine—GSTP1—Cellular responses to stress—TP53—germ cell cancer	5.22e-06	0.00212	CbGpPWpGaD
Clomipramine—HTR6—GPCR downstream signaling—OXT—germ cell cancer	5.19e-06	0.00211	CbGpPWpGaD
Clomipramine—ALB—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	4.85e-06	0.00197	CbGpPWpGaD
Clomipramine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	4.81e-06	0.00195	CbGpPWpGaD
Clomipramine—ALB—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	4.77e-06	0.00194	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—OXT—germ cell cancer	4.73e-06	0.00192	CbGpPWpGaD
Clomipramine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—germ cell cancer	4.72e-06	0.00192	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—OXT—germ cell cancer	4.71e-06	0.00191	CbGpPWpGaD
Clomipramine—HRH2—GPCR downstream signaling—AVP—germ cell cancer	4.63e-06	0.00188	CbGpPWpGaD
Clomipramine—HTR2C—GPCR ligand binding—AVP—germ cell cancer	4.63e-06	0.00188	CbGpPWpGaD
Clomipramine—SLC6A2—Transmembrane transport of small molecules—AVP—germ cell cancer	4.45e-06	0.00181	CbGpPWpGaD
Clomipramine—ALB—SLC-mediated transmembrane transport—AVP—germ cell cancer	4.4e-06	0.00179	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—OXT—germ cell cancer	4.3e-06	0.00175	CbGpPWpGaD
Clomipramine—ABCB1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	4.25e-06	0.00172	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—AVP—germ cell cancer	4.21e-06	0.00171	CbGpPWpGaD
Clomipramine—ABCB1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	4.18e-06	0.0017	CbGpPWpGaD
Clomipramine—ALB—Folate Metabolism—TP53—germ cell cancer	4.16e-06	0.00169	CbGpPWpGaD
Clomipramine—ALB—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	4.09e-06	0.00166	CbGpPWpGaD
Clomipramine—HTR2A—GPCR ligand binding—AVP—germ cell cancer	4.02e-06	0.00163	CbGpPWpGaD
Clomipramine—SLC6A4—Circadian rythm related genes—TP53—germ cell cancer	3.95e-06	0.0016	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—OXT—germ cell cancer	3.82e-06	0.00155	CbGpPWpGaD
Clomipramine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—germ cell cancer	3.71e-06	0.00151	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	3.67e-06	0.00149	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR ligand binding—AVP—germ cell cancer	3.66e-06	0.00149	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—OXT—germ cell cancer	3.63e-06	0.00147	CbGpPWpGaD
Clomipramine—HTR6—GPCR downstream signaling—AVP—germ cell cancer	3.55e-06	0.00144	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—OXT—germ cell cancer	3.47e-06	0.00141	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—OXT—germ cell cancer	3.32e-06	0.00135	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—AVP—germ cell cancer	3.24e-06	0.00132	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—AVP—germ cell cancer	3.23e-06	0.00131	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—FGF4—germ cell cancer	3.1e-06	0.00126	CbGpPWpGaD
Clomipramine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—germ cell cancer	3.07e-06	0.00125	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—OXT—germ cell cancer	3.02e-06	0.00122	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—OXT—germ cell cancer	3.01e-06	0.00122	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—AVP—germ cell cancer	2.95e-06	0.0012	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—SLC2A3—germ cell cancer	2.88e-06	0.00117	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	2.86e-06	0.00116	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—SLC22A3—germ cell cancer	2.83e-06	0.00115	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—OXT—germ cell cancer	2.78e-06	0.00113	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—H2AFZ—germ cell cancer	2.76e-06	0.00112	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—OXT—germ cell cancer	2.74e-06	0.00111	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—AVP—germ cell cancer	2.62e-06	0.00106	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—KITLG—germ cell cancer	2.54e-06	0.00103	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—OXT—germ cell cancer	2.54e-06	0.00103	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—AVP—germ cell cancer	2.49e-06	0.00101	CbGpPWpGaD
Clomipramine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—germ cell cancer	2.48e-06	0.00101	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—AVP—germ cell cancer	2.38e-06	0.000965	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—FGF4—germ cell cancer	2.37e-06	0.000964	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—CRABP1—germ cell cancer	2.31e-06	0.000938	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—AVP—germ cell cancer	2.27e-06	0.000923	CbGpPWpGaD
Clomipramine—ALB—Metabolism—SLC2A3—germ cell cancer	2.27e-06	0.000922	CbGpPWpGaD
Clomipramine—ALB—Metabolism—SLC22A3—germ cell cancer	2.24e-06	0.000908	CbGpPWpGaD
Clomipramine—ALB—Transmembrane transport of small molecules—AVP—germ cell cancer	2.24e-06	0.000908	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—FGF4—germ cell cancer	2.17e-06	0.00088	CbGpPWpGaD
Clomipramine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—germ cell cancer	2.15e-06	0.000874	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—H2AFZ—germ cell cancer	2.12e-06	0.000861	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—AVP—germ cell cancer	2.07e-06	0.00084	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—AVP—germ cell cancer	2.06e-06	0.000838	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—OXT—germ cell cancer	2.05e-06	0.000832	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—SLC2A3—germ cell cancer	2.04e-06	0.000827	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—SLC22A3—germ cell cancer	2.01e-06	0.000815	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—SLC2A3—germ cell cancer	1.99e-06	0.000808	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—SLC22A3—germ cell cancer	1.96e-06	0.000796	CbGpPWpGaD
Clomipramine—ABCB1—Transmembrane transport of small molecules—AVP—germ cell cancer	1.96e-06	0.000795	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—KITLG—germ cell cancer	1.95e-06	0.000792	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—H2AFZ—germ cell cancer	1.94e-06	0.000786	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—AVP—germ cell cancer	1.91e-06	0.000774	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	1.89e-06	0.000769	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—FGFR3—germ cell cancer	1.89e-06	0.000768	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—AVP—germ cell cancer	1.88e-06	0.000762	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—SLC2A3—germ cell cancer	1.87e-06	0.000761	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—SLC22A3—germ cell cancer	1.85e-06	0.00075	CbGpPWpGaD
Clomipramine—ALB—Metabolism—CRABP1—germ cell cancer	1.82e-06	0.00074	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—KITLG—germ cell cancer	1.78e-06	0.000723	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—OXT—germ cell cancer	1.78e-06	0.000722	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—FGF4—germ cell cancer	1.75e-06	0.00071	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—AVP—germ cell cancer	1.74e-06	0.000707	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—KIT—germ cell cancer	1.74e-06	0.000705	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—CRABP1—germ cell cancer	1.64e-06	0.000664	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—OXT—germ cell cancer	1.62e-06	0.000657	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—CRABP1—germ cell cancer	1.6e-06	0.000648	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—SLC2A3—germ cell cancer	1.59e-06	0.000645	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—SLC22A3—germ cell cancer	1.56e-06	0.000635	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—H2AFZ—germ cell cancer	1.56e-06	0.000634	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	1.56e-06	0.000632	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—FGF4—germ cell cancer	1.52e-06	0.000617	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—CRABP1—germ cell cancer	1.51e-06	0.000611	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—FGFR3—germ cell cancer	1.45e-06	0.000589	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—KITLG—germ cell cancer	1.44e-06	0.000583	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—AVP—germ cell cancer	1.4e-06	0.00057	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—FGF4—germ cell cancer	1.38e-06	0.000561	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—H2AFZ—germ cell cancer	1.36e-06	0.000551	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—KIT—germ cell cancer	1.33e-06	0.00054	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—FGFR3—germ cell cancer	1.32e-06	0.000537	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—CRABP1—germ cell cancer	1.28e-06	0.000518	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—HRAS—germ cell cancer	1.27e-06	0.000516	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—KITLG—germ cell cancer	1.25e-06	0.000506	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—H2AFZ—germ cell cancer	1.23e-06	0.000501	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—SLC2A3—germ cell cancer	1.23e-06	0.000498	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—AVP—germ cell cancer	1.22e-06	0.000495	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—KIT—germ cell cancer	1.22e-06	0.000493	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—SLC22A3—germ cell cancer	1.21e-06	0.00049	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—KITLG—germ cell cancer	1.13e-06	0.000461	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—AVP—germ cell cancer	1.11e-06	0.00045	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—FGFR3—germ cell cancer	1.07e-06	0.000433	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—TP53—germ cell cancer	1.03e-06	0.000419	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—HRAS—germ cell cancer	9.87e-07	0.000401	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CRABP1—germ cell cancer	9.84e-07	0.0004	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—KIT—germ cell cancer	9.8e-07	0.000398	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—HRAS—germ cell cancer	9.74e-07	0.000395	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—MYC—germ cell cancer	9.55e-07	0.000388	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—FGFR3—germ cell cancer	9.27e-07	0.000376	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—HRAS—germ cell cancer	8.89e-07	0.000361	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—KIT—germ cell cancer	8.51e-07	0.000346	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—FGFR3—germ cell cancer	8.44e-07	0.000342	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—TP53—germ cell cancer	8.15e-07	0.000331	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—TP53—germ cell cancer	7.84e-07	0.000318	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—HRAS—germ cell cancer	7.79e-07	0.000316	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—KIT—germ cell cancer	7.74e-07	0.000314	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—HRAS—germ cell cancer	7.5e-07	0.000305	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—MYC—germ cell cancer	7.32e-07	0.000297	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—HRAS—germ cell cancer	7.17e-07	0.000291	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—MYC—germ cell cancer	6.69e-07	0.000271	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—HRAS—germ cell cancer	6.23e-07	0.000253	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—TP53—germ cell cancer	6.02e-07	0.000244	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—HRAS—germ cell cancer	5.75e-07	0.000234	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—HRAS—germ cell cancer	5.67e-07	0.00023	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—TP53—germ cell cancer	5.49e-07	0.000223	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—MYC—germ cell cancer	5.39e-07	0.000219	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—HRAS—germ cell cancer	5.25e-07	0.000213	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—MYC—germ cell cancer	4.68e-07	0.00019	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—TP53—germ cell cancer	4.43e-07	0.00018	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—MYC—germ cell cancer	4.26e-07	0.000173	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—HRAS—germ cell cancer	4.24e-07	0.000172	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—TP53—germ cell cancer	3.85e-07	0.000156	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—HRAS—germ cell cancer	3.68e-07	0.000149	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—TP53—germ cell cancer	3.5e-07	0.000142	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—HRAS—germ cell cancer	3.35e-07	0.000136	CbGpPWpGaD
